Blog

- NOVEL DISCOVERIES

‘Guided missile’ drug molecule seeks out and destroys cancer’s genetic lifeline

Researchers have created a new type of drug molecule that can precisely destroy TERRA, an RNA molecule that helps certain cancer cells survive. Using advanced “RIBOTAC” technology, their compound finds TERRA inside cells and breaks it down without harming healthy molecules. This discovery could pave the way for a new generation of RNA-based cancer treatments, targeting the disease at its genetic roots rather than just its symptoms.

Read More »

Elkem introduces new biocompatible, electro conductive SILBIONE™ Liquid Silicone Rubber for advanced healthcare devices

YORK, S.C., Oct. 23, 2025 /PRNewswire/ — Elkem ASA (ticker: ELK), a global leader in advanced silicon-based materials, today unveiled SILBIONE™ LSR Select EC 70, a next-generation medical-grade liquid silicone rubber. Designed for wearable and diagnostic devices, the material combines high electrical conductivity, certified biocompatibility1, and enhanced process control, setting a new standard for precision healthcare applications.

Read More »

Ingestible pill developed to diagnose intestinal disorder

Researchers led by investigators at Mass General Brigham and Massachusetts Institute of Technology have validated an ingestible capsule in preclinical models for the diagnosis of acute mesenteric ischemia, a condition caused by blocked or reduced blood flow to the intestines. The research is published in Science Robotics.

Read More »

Tears could open new avenue for diagnosing and monitoring eye and neurodegenerative diseases

Ocular fluids provide a window into the health of the eye and the development of various pathologies. However, their study usually involves invasive techniques. “A wide range of eye diseases are being investigated, but the methods for obtaining aqueous humor and vitreous humor, the fluids inside the eye, are highly invasive, which limits their applicability in routine clinical practice,” explains Marta San Roque, Ph.D. student in the Innovation in Vesicles and Cells for Application in Therapy (IVECAT) Group at the Germans Trias i Pujol Research Institute (IGTP).

Read More »